Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Apr 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5034955017 | Cangrelor tetrasodium | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 5034956016 | Cangrelor tetrasodium (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cangrelor tetrasodium | Is a | Substance with P2Y12 G-protein-coupled platelet receptor antagonist mechanism of action (substance) | true | Inferred relationship | Existential restriction modifier | ||
| Cangrelor tetrasodium | Is a | Purine nucleotide | true | Inferred relationship | Existential restriction modifier | ||
| Cangrelor tetrasodium | Is a | Ribonucleotide | true | Inferred relationship | Existential restriction modifier | ||
| Cangrelor tetrasodium | Has disposition | P2Y12 G-protein-coupled platelet receptor antagonist | true | Inferred relationship | Existential restriction modifier | ||
| Cangrelor tetrasodium | Is modification of | Cangrelor | true | Inferred relationship | Existential restriction modifier | ||
| Cangrelor tetrasodium | Is a | Substance with platelet aggregation inhibitor mechanism of action (substance) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cangrelor 50mg powder for solution for injection vials | Has specific active ingredient | True | Cangrelor tetrasodium | Inferred relationship | Existential restriction modifier | |
| Cangrelor 50mg powder for solution for injection vials 10 vial | Has specific active ingredient | True | Cangrelor tetrasodium | Inferred relationship | Existential restriction modifier | |
| Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (Chiesi Ltd) 10 vial | Has specific active ingredient | True | Cangrelor tetrasodium | Inferred relationship | Existential restriction modifier | |
| Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (Chiesi Ltd) | Has specific active ingredient | True | Cangrelor tetrasodium | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR